Objective: To determine the risk factors for recurrence in endoscopically treated frontoethmoid mucoceles.
Methods: A retrospective study was designed. The patients with frontoethmoidal mucoceles who underwent endonasal surgical approach and followed up for a minimum of 4 years were included. The demographic data of patients, symptoms, etiological and prognostic features, location, and classification of the mucocele were recorded.
Results: Sixty-four patients were included in the study. The mean age of patients was 45.2 [range: 10-83, standard deviation (SD):618.2], and the male: female ratio was 0.72. The mean follow-up duration was 75 months (min. 52, max. 168 months, SD: 42.1). Bone erosion at lamina papyracea was detected in 30 patients (46.9%), orbital roof (n¼ 20, 31.3%), and ethmoid roof (n¼ 15, 23.4%). Major complications were encountered in two patients (% 8). During follow-up (mean: 75 months min. 52, max. 168, SD: 42.1), recurrence was found in eight cases (12.5%). Comparison of risk factors regarding recurrence of mucocele after surgery showed statistical significance for posterior frontal wall dehiscence (P¼ .014) and revision endoscopic surgery (P¼ .005). However, further analysis with binary logistic regression, revision nasal endoscopic sinus surgery was the only significant risk factor for mucocele recurrence (P¼ .047, odds ratio: 6.43).
Conclusion: Endoscopic endonasal marsupialization of frontoethmoid mucoceles is a safe and efficient for management. A long-term follow-up is important for the accurate assessment of recurrence. The presence of revision nasal surgery was a significant risk factor for recurrence, so, more extensive surgeries can be considered to minimize the risk.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Research Article |
| Authors | |
| Publication Date | December 25, 2021 |
| Published in Issue | Year 2021 Volume: 4 Issue: 3 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.